OC.12.1 REAL-LIFE EFFECTIVENESS OF USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CONCOMITANT PSORIASIS OR PSORIATIC ARTHRITIS: AN IG-IBD STUDY

MLA

D. Pugliese, et al. “Oc.12.1 Real-Life Effectiveness of Ustekinumab in Inflammatory Bowel Disease Patients with Concomitant Psoriasis or Psoriatic Arthritis: An Ig-Ibd Study.” Digestive and Liver Disease, vol. 51, Mar. 2019, p. e109. EBSCOhost, https://doi.org/10.1016/s1590-8658(19)30201-4.

APA

D. Pugliese, M. Daperno, G. Fiorino, E. Savarino, E. Mosso, L. Biancone, A. Testa, L. Sarpi, M. Cappello, G. Bodini, F. Caprioli, S. Festa, G. Laino, G. Maconi, S. Mazzuoli, G. Mocci, A. Sartini, A. D’Amore, S. Alivernini, … A. Armuzzi. (2019). Oc.12.1 Real-Life Effectiveness of Ustekinumab in Inflammatory Bowel Disease Patients with Concomitant Psoriasis or Psoriatic Arthritis: An Ig-Ibd Study. Digestive and Liver Disease, 51, e109. https://doi.org/10.1016/s1590-8658(19)30201-4

Chicago

D. Pugliese, M. Daperno, G. Fiorino, E. Savarino, E. Mosso, L. Biancone, A. Testa, et al. 2019. “Oc.12.1 Real-Life Effectiveness of Ustekinumab in Inflammatory Bowel Disease Patients with Concomitant Psoriasis or Psoriatic Arthritis: An Ig-Ibd Study.” Digestive and Liver Disease 51 (March): e109. doi:10.1016/s1590-8658(19)30201-4.